BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 36573834)

  • 1. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Kim GH; Lee K; Shim JO
    Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet and gut microbial associations in irritable bowel syndrome according to disease subtype.
    Wang Y; Ma W; Mehta R; Nguyen LH; Song M; Drew DA; Asnicar F; Huttenhower C; Segata N; Wolf J; Spector T; Berry S; Staller K; Chan AT
    Gut Microbes; 2023 Dec; 15(2):2262130. PubMed ID: 37786251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
    Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
    Choo C; Mahurkar-Joshi S; Dong TS; Lenhart A; Lagishetty V; Jacobs JP; Labus JS; Jaffe N; Mayer EA; Chang L
    Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G134-G143. PubMed ID: 35726867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of Subtypes.
    Matsumoto H; Shiotani A; Katsumata R; Fukushima S; Handa Y; Osawa M; Murao T; Handa O; Umegaki E; Inoue R; Naito Y
    Digestion; 2021; 102(1):49-56. PubMed ID: 33271532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes.
    Villanueva-Millan MJ; Leite G; Wang J; Morales W; Parodi G; Pimentel ML; Barlow GM; Mathur R; Rezaie A; Sanchez M; Ayyad S; Cohrs D; Chang C; Rashid M; Hosseini A; Fiorentino A; Weitsman S; Chuang B; Chang B; Pichetshote N; Pimentel M
    Am J Gastroenterol; 2022 Dec; 117(12):2055-2066. PubMed ID: 36114762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
    Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
    Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methanogen Levels Are Significantly Associated with Fecal Microbiota Composition and Alpha Diversity in Healthy Adults and Irritable Bowel Syndrome Patients.
    Wang T; van Dijk L; Rijnaarts I; Hermes GDA; de Roos NM; Witteman BJM; de Wit NJW; Govers C; Smidt H; Zoetendal EG
    Microbiol Spectr; 2022 Dec; 10(6):e0165322. PubMed ID: 36321894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
    Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
    Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.
    Chen H; Ou R; Tang N; Su W; Yang R; Yu X; Zhang G; Jiao J; Zhou X
    J Transl Med; 2023 Feb; 21(1):117. PubMed ID: 36774467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.